Heather is chuffed as are we that people are listening to what she has to say about the need for medical cannabis….“Now, more than ever, cannabis is essential,” Allman declared. “It is crucial that we continue to provide access to cannabis, medical and recreational.”
Turns out that DiZoglio’s hearing wasn’t the only Zoom event that day to reflect on how cannabis companies are responding to the economic threat of COVID-19.
During a separate online media briefing hosted by the Cannabis Information Project, topics ranged from veterans’ loss of medical cannabis due to adult use closures; to the resurgence of the illicit marijuana market; to the challenges the patchwork of different state regulations pose.
And ultimately such state-vs.-state and federal-vs.-state differences take an economic toll, speakers agreed. “The decision to limit recreational sales in some states, as well as the limits in curbside pickup in others, has hampered the industry’s ability to be an instrumental economic engine at a time when our country needs it the most,” pointed out Linda Greene, who is owner and CEO of Anacostia Organics.
That message fell on the sympathetic ears of nine other industry professionals, who included other company executives like Greene, a cannabis pharmacist and a certified cannabis educator. That educator, Heather Allman, underlined the medical benefits of cannabis by introducing herself as a multiple sclerosis sufferer. Until she embarked on a medical cannabis course of treatment, Allman said, she was confined to a wheelchair and subjected to a regimen of 25 daily medications.
Today, she is walking without assistance and is down to six medications. “Now, more than ever, cannabis is essential,” Allman declared. “It is crucial that we continue to provide access to cannabis, medical and recreational.”
Read the full story at